Efficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)

Basit Öğe Kaydı
dc.contributor.authorYoung, Guy
dc.contributor.authorSrivastava, Alok
dc.contributor.authorKavakli, Kaan
dc.contributor.authorRoss, Cecil
dc.contributor.authorSathar, Jameela
dc.contributor.authorTran, Huyen
dc.contributor.authorWu, Runhui
dc.date.accessioned2023-01-12T20:04:22Z
dc.date.available2023-01-12T20:04:22Z
dc.date.issued2021
dc.departmentN/A/Departmenten_US
dc.description.abstract[No Abstract Available]en_US
dc.identifier.doi10.1182/blood-2021-150273
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.issn0006-4971en_US
dc.identifier.issn1528-0020en_US
dc.identifier.urihttps://doi.org/10.1182/blood-2021-150273
dc.identifier.urihttps://hdl.handle.net/11454/77784
dc.identifier.volume138en_US
dc.identifier.wosWOS:000736398800005en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Hematologyen_US
dc.relation.ispartofBlooden_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleEfficacy and Safety of Fitusiran Prophylaxis, an siRNA Therapeutic, in a Multicenter Phase 3 Study (ATLAS-INH) in People with Hemophilia A or B, with Inhibitors (PwHI)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu